Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
27 Februar 2023 - 3:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of February 2023
(Report No. 5)
Commission file number: 001-38041
SCISPARC LTD.
(Translation of registrant’s name into English)
20 Raul Wallenberg Street, Tower A,
Tel Aviv 6971916 Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
CONTENTS
On February 27, 2023, SciSparc
Ltd. (the “Company”) issued a press release titled “SciSparc Signs Agreement for the Supply of CBD-rich Cannabis Oil
for its Clinical Trial on Children with Autism Spectrum Disorder.” A copy of this press release is furnished herewith as Exhibit
99.1 and incorporated by reference herein.
The first three and the fifth
paragraphs and the section titled “Forward-Looking Statements” in the press release attached hereto as Exhibit 99.1 are incorporated
by reference into the registration statements on Form F-3 (File No. 333-269839, File No. 333-266047, File No. 333-233417 and File No.
333-248670) and on Form S-8 (File No. 333-225773) filed with the Securities and Exchange Commission to be a part thereof from the date
on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
SciSparc Ltd. |
|
|
|
Date: February 27, 2023 |
By: |
/s/ Oz Adler |
|
Name: |
Oz Adler |
|
Title: |
Chief Executive Officer and
Chief Financial Officer |
3
Therapix Biosciences (NASDAQ:TRPX)
Historical Stock Chart
Von Aug 2024 bis Sep 2024
Therapix Biosciences (NASDAQ:TRPX)
Historical Stock Chart
Von Sep 2023 bis Sep 2024
Echtzeit-Nachrichten über Therapix Biosciences Ltd (NASDAQ): 0 Nachrichtenartikel
Weitere Scisparc Ltd. News-Artikel